$Cassava Sciences (SAVA.US)$ Over 1900 people in a Phase 3 A...
$Cassava Sciences(SAVA.US$ Over 1900 people in a Phase 3 AD trial that the shorts/Hedge funds delayed and tried to stop but failed. These 1900 people have been getting treatment and there have been no cries or stops of these SAVA trials for side effects( Other companies had to stop their trials for brain bleeding and deaths). On the contrary, SAVA's has received MOA, FDA SPA Agreement , cognition improvement in mild patients, patient testimony and discovering more potential use with Filamin A, protein repair. These are plenty of positives that show how much the world will benefit from this and it will be making history. The stock manipulation will definitely come to a halt as the shorts cannot silence that many people that are improving. We will protect SAVA so that people with AD get the opportunity to treat a debilitating disease!
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment
